Products

Instapoints

Conoce mejor a tus clientes. Dales razones para volver.

instapoints.com.mx Marketing / Conversion Optimization & Social Proof

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$9.95/mo
Lower than 72% of peersNiche median $19.99/mo
Launched
3y ago
2023-05-25 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Create a digital loyalty plan for your business in minutes

    May 25, 2023 · 3y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered 2022-01-31

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Fidelización Instapoints
$199 MXN / mes

Trial: Comienzas con 7 días gratis, sin tarjeta de crédito. · Observed 2026-11-08 · Source page

Entry price $9.95/mo, Lower than 72% of peers; “Conversion Optimization & Social Proof” median is $19.99/mo.View pricing benchmark

Website snapshots

Indexed 2023-05-25

Key pages

Desktop & mobile archive
Home
instapoints.com.mx/ Snapshot 2026-11-08

Questions & evidence

How much does Instapoints cost?
Fidelización Instapoints: $199 MXN / mes. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Instapoints get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Instapoints and what platforms does it support?
Instapoints is catalogued under Conversion Optimization & Social Proof: Conoce mejor a tus clientes. Dales razones para volver. Supported platforms: Web.

Related products in this category

Marketing / Conversion Optimization & Social Proof

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.